T1	Pharmacological_substance 10 22	Fluphenazine
N1000 	Reference T1 MeSH:D005476	Fluphenazine
T2	Disorder 31 61	neuroleptic malignant syndrome
N1 	Reference T2 UMLS:C0027849	neuroleptic malignant syndrome
T3	Disorder 67 80	schizophrenic
N2 	Reference T3 UMLS:C0036341	schizophrenic
T4	Disorder 122 152	neuroleptic malignant syndrome
N3 	Reference T4 UMLS:C0027849	neuroleptic malignant syndrome
T5	Disorder 154 157	NMS
N4 	Reference T5 UMLS:C0270699	NMS
N5 	Reference T5 UMLS:C0027849	NMS
T6	Pharmacological_substance 175 187	fluphenazine
N1001 	Reference T6 MeSH:D005476	fluphenazine
T7	Disorder 193 206	schizophrenic
N6 	Reference T7 UMLS:C0036341	schizophrenic
T8	Disorder 323 336	schizophrenia
N7 	Reference T8 UMLS:C0036341	schizophrenia
T10	Disorder 588 603	muscle rigidity
N8 	Reference T10 UMLS:C0026837	muscle rigidity
T11	Disorder 616 623	tremors
N9 	Reference T11 UMLS:C0040822	tremors
T12	Disorder 645 656	psychiatric
T13	Disorder 681 694	schizophrenia
N10 	Reference T13 UMLS:C0036341	schizophrenia
T15	Pharmacological_substance 827 849	fluphenazine decanoate
N1002 	Reference T15 MeSH:C011825	fluphenazine decanoate
T16	Pharmacological_substance 927 939	thioridazine
N1003 	Reference T16 MeSH:D013881	thioridazine
T17	Pharmacological_substance 944 955	haloperidol
N1004 	Reference T17 MeSH:D006220	haloperidol
T18	Disorder 1018 1037	aggressive behavior
N11 	Reference T18 UMLS:C0677505	aggressive behavior
N12 	Reference T18 UMLS:C0677505	aggressive behavior
T25	Disorder 1246 1254	azotemia
N13 	Reference T25 UMLS:C0242528	azotemia
N14 	Reference T25 UMLS:C0554309	azotemia
T26	Disorder 1256 1273	hyperphosphatemia
N15 	Reference T26 UMLS:C0085681	hyperphosphatemia
T27	Disorder 1275 1287	hypocalcemia
N16 	Reference T27 UMLS:C0020598	hypocalcemia
T28	Disorder 1293 1305	leukocytosis
N17 	Reference T28 UMLS:C0023518	leukocytosis
T29	Pharmacological_substance 1380 1397	neuroleptic drugs
N1005 	Reference T29 MeSH:D014150	neuroleptic drugs
T31	Pharmacological_substance 1461 1473	neuroleptics
N1006 	Reference T31 MeSH:D014150	neuroleptics
T32	Disorder 1515 1526	dehydration
N18 	Reference T32 UMLS:C0011175	dehydration
T33	Disorder 1528 1537	agitation
N19 	Reference T33 UMLS:C0085631	agitation
T34	Pharmacological_substance 1668 1680	fluphenazine
N1007 	Reference T34 MeSH:D005476	fluphenazine
T35	Pharmacological_substance 1766 1778	thioridazine
N1008 	Reference T35 MeSH:D013881	thioridazine
T36	Pharmacological_substance 1786 1797	haloperidol
N1009 	Reference T36 MeSH:D006220	haloperidol
T37	Pharmacological_substance 1934 1947	psychotropics
N1010 	Reference T37 MeSH:D011619	psychotropics
T39	Subject 81 88	patient
T43	Subject 207 214	patient
T45	Subject 282 317	A 21-year-old African American male
T47	Disorder 425 437	hyperthermic
N20 	Reference T47 UMLS:C0015967	hyperthermic
T48	Disorder 473 485	diaphoretic,
N21 	Reference T48 UMLS:C0700590	diaphoretic,
T49	Disorder 486 497	tachycardic
N22 	Reference T49 UMLS:C0039231	tachycardic
T50	Disorder 530 540	tachypneic
N23 	Reference T50 UMLS:C0231835	tachypneic
T52	Coreferring_mention 800 802	he
T53	Disorder 988 1002	verbal threats
T56	Disorder 1319 1322	NMS
N24 	Reference T56 UMLS:C0270699	NMS
N25 	Reference T56 UMLS:C0027849	NMS
T30	Pharmacological_substance 1579 1590	neuroleptic
N1011 	Reference T30 MeSH:D014150	neuroleptic
T64	Disorder 1707 1710	NMS
N26 	Reference T64 UMLS:C0270699	NMS
N27 	Reference T64 UMLS:C0027849	NMS
T66	Speculation_cue 1689 1697	probable
T69	Disorder 1741 1749	reaction
T71	Negation_cue 1738 1740	no
T73	Speculation_cue 1866 1875	potential
T19	Manner_cue 1337 1354	potentially fatal
T20	Coreferring_mention 1399 1401	It
T14	Combination 879 887	addition
